Moderate to Severe Nail Psoriasis
2 clinical trials · Condition
◉ Watch Moderate to Severe Nail Psoriasis
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail Psoriasis (NCT03897075) | Sun Pharmaceutical Industries Limited | 2021-05-13 |
| Study of Safety, Tolerability, and Efficacy of Secukinumab in Subjects With Moderate to Severe Nail Psoriasis (NCT01807520) | Novartis Pharmaceuticals | 2013-06-20 |
Track Moderate to Severe Nail Psoriasis automatically
Every clearance here is in the API, with alerts when new ones post.